A Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Particpants 6 Years and Older and F/MF Genotypes
Clinical trial NCT04545515 · COMPLETED
Trial details
- NCT number
- NCT04545515
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2023-03-24
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.